Pure Global
NCT05978830

Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection.

The Development of Early-stage Alzheimer's Disease Multimodal Fusion Warning System and Non-invasive Neurostimulation Techniques.
First Affiliated Hospital of Zhejiang University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Alzheimer's Disease
Drug/Device/Intervention
Transcranial ultrasound stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
First Affiliated Hospital of Zhejiang University
Location
Hangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2022
End date
Dec 30, 2024
Enrollment
100 participants
Primary outcome

Power spectrum,Duration of microstate,Occurrence of microstate,Mini-Mental State Examination (MMSE),Montreal Cognitive Assessment (MoCA)

Summary

Developing and validating an early digitalized recognition device and multimodal warning
 model for Alzheimer's disease, and establishing a precision transcranial ultrasound
 stimulation intervention system.

ICD-10 classifications
Alzheimer diseaseAlzheimer disease, unspecifiedOther Alzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05978830
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05978830 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital of Zhejiang University and is currently Recruiting. The study focuses on Alzheimer's Disease. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.